Furthermore, the level of NUSAP1 was enhanced in dead patients who had been diagnosed with glioma (Fig. 1d), and patients with high expression of NUSAP1 showed lower survival (Supplementary Fig. S1a). Here, NUSAP1 is linked to central nervous system cancer.